Karyopharma Shares Recently Spiked Higher; Hearing Co. Granted Orphan Drug Status For Its Myelodysplastic Syndrome Treatment
https://twitter.com/algobotnews/status/1483891738460700674
Karyopharm, Menarini Ink Over $200M Licensing Pact For Selinexor In Europe, Other Territories
Karyopharm Therapeutics Inc (NASDAQ: KPTI) and the Menarini Group
Cannabis Movers & Shakers: Coda Signature, Greater Cannabis Co., BioHarvest Sciences, Compass Pathways
Coda Signature Taps Teddy C. Scott As Board Member
Producer of cannabis-infused edibles and wellness products Coda Signature recently appointed Teddy C. Scott, Ph.D., J.D to serve on the board of directors.
Morgan Stanley Downgrades Karyopharm Therapeutics to Equal-Weight, Lowers Price Target to $10
Morgan Stanley analyst Michael Ulz downgrades Karyopharm Therapeutics (NASDAQ:KPTI) from Overweight to Equal-Weight and lowers the price target from $27 to $10.
Karyopharm Announces New Interim Phase 2 Selinexor Data In Myelofibrosis Selected For Oral Presentation At American Society Of Hematology 2021 Annual Meeting And Exposition
Karyopharm Therapeutics Inc. (NASDAQ:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that an abstract detailing new data from a Phase 2 study evaluating selinexor, a
86 Biggest Movers From Yesterday
Gainers
FAT Brands Inc. (NASDAQ: FATBB) shares gained 99.2% to settle at $15.44. FAT Brands recently announced plans to acquire Fazoli’s Restaurant Chain for $130 million.
Mid-Afternoon Market Update: Nasdaq Rises 60 Points; Federal Reserve Slows Down Bond Buying
Toward the end of trading Wednesday, the Dow traded down 0.15% to 35,997.82 while the NASDAQ rose 0.38% to 15,709.60. The S&P also rose, gaining 0.13% to 4,636.89.
Mid-Day Market Update: Crude Oil Drops Over 3%; R.R.Donnelley & Sons Shares Jump
Midway through trading Wednesday, the Dow traded down 0.21% to 35,978.38 while the NASDAQ rose 0.08% to 15,662.87. The S&P also fell, dropping 0.10% to 4,625.81.